Navigation Links
Children of undocumented parents may be at higher developmental risk
Date:7/13/2009

Undocumented people live in a shadowy world of high fear and stress -- fear of deportation and stress brought on lack of economic, linguistic and educational resources.

And of course if they are parents their worries trickle down to their children. A new study from UCLA examines parents' concerns about development, learning and behavior for young children of Mexican origin and identifies whether these concerns differ by the families' citizenship or documentation status.

The study appears in the July-August issue of the journal Academic Pediatrics. It shows that, as reported by the parent, Mexican children with an undocumented parent have greater developmental risk than do Latino and white children whose parents are documented or who are U.S. citizens.

"In the United States, nearly 4.9 million or 25 percent of children younger than five years old are Latino, which makes them the largest group of young minority children," said Alexander Ortega, a professor of public health and a professor of psychiatry at the UCLA Semel Institute for Neuroscience and Human Behavior. "That's huge. With Mexicans as the vast majority of Latino children 64 percent understanding their health, well-being and the development of Mexican children is critical, given future U.S. demographic changes."

He added that the concern "is there are a significant number of children with an undocumented parent whose developmental risks may be missed by the health care sector."

What's less clear, say the authors, is what's causing the concern. Few studies have examined the impact of immigration on children's development and behavior. Studies have identified that immigrant children tend to have more behavioral problems and learning difficulties in school, which may be attributable to immigration stress. Another study found that a majority of Mexican immigrant mothers perceived their children as having significant delays in language sk
'/>"/>

Contact: Mark Wheeler
mwheeler@mednet.ucla.edu
310-794-2265
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Children of depressed moms do better when dad is involved, SLU researcher finds
2. High pollution linked to poor lung function growth in children in Mexico City
3. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
4. Obese Children Miss More School Days
5. Ultra-Runner to Run 63 Marathons in 63 Days for Children with Incurable Disease
6. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Practice-based intervention has sustained benefits for children and families
10. 1.5 million children could be saved
11. Annual flu shot cuts need for doctors visits, hospitalization among children
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 1Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 2Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 3Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 4Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 5Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 6Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 7Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 8Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 9Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 10Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 11Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 12Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 13Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 14Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 15Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 16Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 17Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics 3rd Edition The Report 14262 18The 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston MA Hynes Convention Center October 31 November 3 20 5061 1The 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston MA Hynes Convention Center October 31 November 3 20 5061 2American Society of Plastic Surgeons hosts 78th annual meeting 58275 1American Society of Plastic Surgeons hosts 78th annual meeting 58275 2American Society of Plastic Surgeons hosts 78th annual meeting 58275 3